Navigation Links
Sentrx Exits 2008 with Strong Growth
Date:1/20/2009

Sentrx, a New Jersey drug safety specialty firm, announced today that the company grew the number of pharmacovigilance outsourcing contracts by more than 50% in 2008. Revenues for the year increased 25% over 2007. The domestic service provider added long-term contracts in clinical trial and post-marketing safety, managed safety system hosting, and risk evaluation and mitigation strategies. The company maintained its strong record of regulatory compliance during this period of growth.

Little Falls, NJ (PRWEB) January 20, 2009 - Sentrx, the leading provider of drug safety services, announced today that the company grew the number of pharmacovigilance outsourcing contracts by more than 50% in 2008. Revenues for the year increased 25% over 2007.

Sentrx pioneered the concept of drug safety outsourcing and safety system hosting for clinical trials and post-marketed products in 1999. Since that time, Sentrx has provided operational and consulting services to nearly eighty unique clients. More than fifty of those companies have outsourced adverse event processing, safety system management, or risk evaluation and mitigation strategies (REMS) to Sentrx.

Sentrx provides services from its headquarters in Little Falls, NJ. In addition to a staff of office-based health care professionals, the company utilizes its network of highly experienced drug safety investigators across the United States. This flexible workforce allows Sentrx to handle volume fluctuations and extended coverage hours for its clients, which benefit from the quality, reliability and convenience of a domestic service provider.

Highlights of new business in 2008 include:

¨ Managed safety system hosting for seven biopharmaceutical companies and a large generic manufacturer
¨ Post-marketing safety surveillance for two specialty pharmaceutical companies
¨ Clinical trial safety monitoring for four biopharmaceutical companies
¨ REMS with Elements to Assure Safe Use for a biopharmaceutical company
¨ Safety system consulting engagements at three large companies
¨ Data migration projects at two specialty pharmaceutical companies
¨ Risk management plans authored and approved for two New Drug Applications
¨ Contract renewal and expansion with several existing clients

Other accomplishments in 2008 include:

¨ Installation of Phase Forward's Empirica™ Trace 4.2 in the Sentrx Hosting Center
¨ Implementation of the first hosted client on Empirica Trace
¨ Positive results from seventeen qualification inspections and client audits
¨ Participation in eleven regulatory health authority inspections conducted at client sites with no major findings

"Growing revenue 25 % is a great accomplishment for Sentrx," said Joseph Albano, Chief Executive Officer of Sentrx, "but I am most proud of our consistent record of compliance. As our client base grows, so does the level of scrutiny our people, processes and technology undergo. The regulatory audit results combined with our financial results demonstrate that Sentrx is the drug safety services provider that companies can rely on."

About Sentrx
Sentrx is a leading provider of technology-enabled solutions and services for global drug safety. Its mission is to help pharmaceutical, biotechnology, medical device, and consumer health companies document the safety profile of their products during clinical development and post-approval, enabling them to minimize risks and maximize benefits. Through its multilingual Safety Response Center in Little Falls, NJ, Sentrx delivers a unique combination of highly skilled people, exclusive technology, and best practices in drug safety monitoring. To learn more about Sentrx, please call 1-888-399-8032, extension 261; visit the Sentrx website at www.sentrx.com; or
view the Sentrx movie at www.sentrx.com/impactmovie.

###

Read the full story at http://www.prweb.com/releases/2009/01/prweb1887034.htm.


'/>"/>
Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved

Related biology technology :

1. Matching Genetics, Technology and Management Practices Critical to Meeting Strong Demand for Agricultural Crops
2. China Biologic Products Reports Strong Third Quarter 2008 Results
3. ACORN CRO Continues Growth in Strong Third Quarter
4. Varian, Inc. Reports Strong Fourth Quarter 2008 Results
5. OmniComm Systems, Inc. Is Fueled by Another Strong Quarter Delivering Electronic Data Capture (EDC) Solutions & Services
6. Shires New Product Portfolio Delivers Strong Quarterly Performance
7. Cephalon Reports Another Strong Quarter
8. Innovation and Strong Therapeutic Potential Seen in Adult Stem Cells, According to Frost & Sullivan
9. Strong elasticity size effects in ZnO nanowires
10. Senetek Affirms Strong Financial Position
11. Dry adhesive based on carbon nanotubes gets stronger, with directional gripping ability
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/12/2016)... , Feb. 12, 2016  PTC Therapeutics, Inc. ... annual STRIVE (Strategies to Realize Innovation, Vision and ... (DMD). STRIVE provides funds to patient advocacy organizations ... make meaningful contributions to the rare disease community ... of future patient advocates. Mary ...
(Date:2/11/2016)... 2016  Vermillion, Inc. (NASDAQ: VRML ), a ... the formation of the Steering Committee for its Pelvic ... --> Pelvic masses can present physicians and healthcare ... pregnancy is ruled out, pelvic masses may include cancers ... benign ovarian tumors and gastrointestinal and urinary tract masses. ...
(Date:2/11/2016)... 2016  Wellcentive today announced it has been ... -based community care organization (CCO) with more ... quality reporting and care management solutions and services. ... of quality managers, analysts and care managers while ... serving FamilyCare members. Oregon ...
(Date:2/11/2016)... , Feb. 11, 2016   BioInformant announces ... "Stem Cell Research Products, Opportunities, Tools, and Technologies – ... The ... the stem cell industry, BioInformant has more than a ... stem cell market, by stem cell type. This powerful ...
Breaking Biology Technology:
(Date:2/3/2016)... -- Vigilant Solutions announces today that the ... solved two recent hit-and-run cases with the ... Solutions. Brian Wenberg explains, "I was ... out of a convenience store and witnessed an elderly male back out ... his vehicle and leaving the scene.  In his statement ...
(Date:2/2/2016)... 2, 2016  BioMEMS devices deployed in ... on medical screening and diagnostic applications, such ... devices that facilitate and assure continuous monitoring ... are being bolstered through new opportunities offered ... acquisition coupled with wireless connectivity and low ...
(Date:2/2/2016)... NEW YORK , Feb. 2, 2016 /PRNewswire/ ... Potentials of that Rising Market Are you ... new analysis forecasts revenues for checkpoint inhibitors. Visiongain,s ... world market, submarket, product and national level. ... Instead discover what progress, opportunities and revenues those ...
Breaking Biology News(10 mins):